Balyasny Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,198
| Closed | -$201K | – | 1881 |
|
|
2024
Q1 | $201K | Buy |
+14,198
| New | +$201K | ﹤0.01% | 1784 |
|
|
2022
Q4 | – | Sell |
-3,273
| Closed | -$31K | – | 2287 |
|
|
2022
Q3 | $31K | Buy |
3,273
+911
| +39% | +$8.63K | ﹤0.01% | 2042 |
|
|
2022
Q2 | $28K | Buy |
+2,362
| New | +$28K | ﹤0.01% | 1985 |
|
|
2016
Q1 | – | Sell |
-64,498
| Closed | -$6.14M | – | 1043 |
|
|
2015
Q4 | $6.14M | Buy |
64,498
+19,333
| +43% | +$1.84M | 0.04% | 415 |
|
|
2015
Q3 | $3.72M | Buy |
45,165
+13,701
| +44% | +$1.13M | 0.03% | 464 |
|
|
2015
Q2 | $5.11M | Buy |
+31,464
| New | +$5.11M | 0.03% | 433 |
|